In a recent Cell Reports jouirnal study, researchers evaluated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine-induced immune responses in SARS survivors. Study: SARS-CoV-2 ...
The emergence of the SARS-CoV-2 variant JN.1 has sparked global concern due to its distinct genetic features and heightened infectivity. Carrying more than 30 spike protein mutations, including the ...
A recent study published in the journal Frontiers in Molecular Biosciences applied computational approaches to study the binding mechanisms of the severe acute respiratory syndrome coronavirus 2 (SARS ...
An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains. A monoclonal antibody appears ...
In recent months, omicron (B.1.1.529) became the dominant variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), displaying some degree of immune evasion. 1 The initial omicron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results